Health literacy of patients admitted for elective surgery

por Koster, E. S., Schmidt, A., Philbert, D., van de Garde, E. M. W., Bouvy, M. L.
Publicado 2016

Preoperative statin therapy and infectious complications in cardiac surgery

por Hartholt, N. L., Rettig, T. C. D., Schijffelen, M., Morshuis, W. J., van de Garde, E. M. W., Noordzij, P. G.
Publicado 2014

[89Zr]-immuno-PET prediction of response to rituximab treatment in patients with therapy refractory interstitial pneumonitis: a phase 2 trial

por Adams, H., van de Garde, E. M. W., Vugts, D. J., Grutters, J. C., Oyen, Wim. J.G., Keijsers, R. G.
Publicado 2023

Chloroquine-induced QTc prolongation in COVID-19 patients

por van den Broek, M. P. H., Möhlmann, J. E., Abeln, B. G. S., Liebregts, M., van Dijk, V. F., van de Garde, E. M. W.
Publicado 2020

The association between gut microbiome affecting concomitant medication and the effectiveness of immunotherapy in patients with stage IV NSCLC

por Verschueren, M. V., van der Welle, C. M. Cramer -, Tonn, M., Schramel, F. M. N. H., Peters, B. J. M., van de Garde, E. M. W.
Publicado 2021

Real-World Results of Ocrelizumab Treatment for Primary Progressive Multiple Sclerosis

por Daniels, K., van der Nat, P. B., Frequin, S. T. F. M., van der Wees, P. J., Biesma, D. H., Hoogervorst, E. L. J., van de Garde, E. M. W.
Publicado 2020

Long-term treatment with metformin in obese, insulin-resistant adolescents: results of a randomized double-blinded placebo-controlled trial

por van der Aa, M P, Elst, M A J, van de Garde, E M W, van Mil, E G A H, Knibbe, C A J, van der Vorst, M M J
Publicado 2016

Decision support systems for incurable non-small cell lung cancer: a systematic review

por Révész, D., Engelhardt, E. G., Tamminga, J. J., Schramel, F. M. N. H., Onwuteaka-Philipsen, B. D., van de Garde, E. M. W., Steyerberg, E. W., Jansma, E. P., De Vet, H. C. W., Coupé, V. M. H.
Publicado 2017

Individual patient data to allow a more elaborated comparison of trial results with real-world outcomes from first-line immunotherapy in NSCLC

por Ismail, R. K., Schramel, F. M. N. H., van Dartel, M., Pasmooij, A. M. G., Cramer-van der Welle, C. M., Hilarius, D. L., de Boer, A., Wouters, M. W. J. M., van de Garde, E. M. W.
Publicado 2023

Correction: Individual patient data to allow a more elaborated comparison of trial results with real-world outcomes from second-line immunotherapy in NSCLC

por Ismail, R. K., Schramel, F. M. N. H., van Dartel, M., Pasmooij, A. M. G., der Welle, C. M. Cramer-van, Hilarius, D. L., de Boer, A., Wouters, M. W. J. M., van de Garde, E. M. W.
Publicado 2023